VINP-28

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameVINP-28

Drug Alias NameVLA4 analog peptide-bound nanoparticle (Massachusetts General Hospital)VCAM-1-targeting nanoparticle (Massachusetts General Hospital)VINP-28

ClassificationBiologics > Protein drugs > Recombinant polypeptide

Mechanisms of ActionIntegrin alpha-4 modulatorsVascular cell adhesion molecule 1 modulators

TargetsVascular cell adhesion molecule 1Integrin alpha-4

Therapy Area/IndicationsAtherosclerosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesThe General Hospital Corporation D/B/A Massachusetts General Hospital

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesThe General Hospital Corporation D/B/A Massachusetts General Hospital

Active IndicationsN/A

Inactive IndicationsAtherosclerosis

Other Information

ATC CodeN/A